A genetic testing technique that helped identify the COVID-19 virus is increasingly being used to diagnose difficult ...

PFE faces COVID revenue declines and a patent cliff, but new products, acquisitions and a strong pipeline could fuel growth ...

The COVID-19 pandemic may be viewed as the single largest disruptor in the history of American healthcare. At Geisinger, the crisis has been a catalyst to accelerate digital transformation. In January ...

The US Food and Drug Administration (FDA) on Tuesday detailed a new “special emergency program” for accelerating research and development of potential treatments for coronavirus disease (COVID-19).

COVID-19 infections and hospital-setting cases have climbed across the United Kingdom this autumn as the XFG variant, widely ...

The US Food and Drug Administration (FDA) on Monday evening issued two guidances intended to accelerate the development of products to treat or prevent coronavirus disease (COVID-19), laying out ...